
Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Evaluating Post-Intervention Treatment Options for PAD
2) The @cardiomet_ce program is supported by educational grants from AstraZeneca, Bayer, Boehringer Ingelheim Pharmaceuticals Inc and Eli Lilly...
Preventing Hyperkalemia from Derailing Evidence-Based CV Care
2) This #accredited #tweetorial series on #kidneydisease #hyperkalemia is supported by an independent educational grant from AstraZeneca and is...
Optimizing Medical Therapy for Patients with HFrEF
1b) @ValleAlfonso is Jefe Servicio Cardiologia, Área del Corazón, Marina Salud. Denia Servicio de Cardiología Hospital La Salud, Valencia. He is a...
Challenging Case Presentations for the Management of Patients with Cardiometabolic Disease
2) She is a member of UKCPA Diabetes & Endocrinology committee @UKCPADiabetes & works across #diabetes, #endocrinology, &...
Current Recommendations and Standards of Care for Treating T2D with SGLT2 Receptor Inhibitors
@AndrewJSauer @DrMichaelShapir @MichaelJBlaha @dramitkhera @pnatarajanmd @PamTaubMD @DrMarthaGulati @DrRaniKhatib @AAgarwalaMD @RpratleyMD...
Clinical and Laboratory Manifestations of DKD in T2D
2a) This activity is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare...
Prevention and Management of Heart Failure in T2 Diabetes: The Cardiologist’s Perspective
2) @GiuseppeGalati_ is at San Raffaele Research Hospital, Milan 🇮🇹 @SanRaffaeleMI. This program is intended for #healthcare professionals & is...
Prevention and Management of Heart Failure in T2 Diabetes: The Diabetologist’s Perspective
1) Welcome to a new #accredited #tweetorial, Prevention and Management of Heart Failure in T2 Diabetes: The Diabetologist’s Perspective! Our expert...
What Every ED and ICU Nurse Should Know About Hypertensive Emergency
1) Welcome to a #tweetorial on what every #ICU #nurse should know about #hypertensive crisis, or #hypertensive #emergency as it is now more properly...
Aggressive Treatment of Elevated LDL-C in the Post-MI and/or Diabetic Patient
1) Welcome to an #accredited #tweetorial on aggressive treatment of elevated #LDL-C in the post-MI and/or #diabetic patient to improve #ASCVD...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.